Galapagos NV - ADR

-1.17 (-1.38%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)5.40B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$132.7 Million
Adjusted EPS-$1.40
See more estimates
10-Day MA$84.74
50-Day MA$97.11
200-Day MA$141.97
See more pivots

Galapagos NV Stock, NASDAQ:GLPG

Industriepark Mechelen Noord, Generaal de Wittelaan L11 A3, Mechelen, Brussels Region 2800
Phone: +32.1.534.29.00
Number of Employees: 1003


Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research & Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.